Trump's Harvard foreign student ban draws rebuke from China
Digest more
Top News
Overview
Impacts
China Mobile, the world's biggest wireless carrier by users, is moving closer to a deal to take over Hong Kong broadband company HKBN after rival bidder I Squared Capital dropped out of the race, three sources said.
Post’s #852 stories series secures third place in best new video or feature category during ceremony in New York.
Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at straitstimes.com. Read more at straitstimes.com.
By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on the Hong Kong Stock Exchange at HK$44.05 a share, the top of its price range,
Hong Kong-traded shares in CATL, the world’s largest maker of batteries for electric vehicles, have jumped after the company raised around $4.6 billion in the biggest initial public offering globally
Chinese battery giant Contemporary Amperex Technology’s shares soared Tuesday in their Hong Kong debut, marking the world’s largest equity offering so far this year. A successful listing of CATL, as the company is known,
Citigroup has launched Citi AI, a suite of artificial intelligence (AI) tools for its employees in Hong Kong, the bank said on Thursday.
Chinese pharmaceutical stocks got a boost from a strong debut of Jiangsu Hengrui Pharmaceuticals, the nation’s biggest drug maker by market capitalisation, which surged 29 per cent on its debut in Hong Kong. CSPC Pharmaceutical Group rallied 4.3 per cent to HK$6.76 and Wuxi AppTec advanced 2.7 per cent to HK$68.90.